Trelleborg inaugurates its facility expansion in Malta. The €14 million investment in cleanrooms & equipment aims to support the life sciences and semiconductor manufacturing industries.
Cambridge Healthcare Innovations (CHI), has announced Quattrii, the first ever dry powder inhaler (DPI) engine that is capable of delivering large volumes of biologic and mRNA molecules in a single inhalation.
Antares Vision Group in collaboration with Oròbix has introduced AI-GO, an artificial intelligence-driven visual inspection platform that elevates standards across several key performance indicators.
Orbia Advance Corporation Fluor & Energy Materials marked the 30th anniversary of its medical propellant brand, Zephex, with an event at its Rocksavage plant in Runcorn, United Kingdom.
Human Data Sciences (HDS) has launched a landmark update to the platform that enables researchers to conduct comparative outcomes studies across multiple endpoints simultaneously.
Despite its growing threat to global health, research aimed at tackling antimicrobial resistance (AMR) has been constrained for many years, most likely due to the rapid evolution of resistance in pathogens, regulatory and policy barriers.
Aragen, a contract research, development and manufacturing organisation (CRDMO), announced that it will commence GMP manufacturing at its biologics manufacturing facility in Bangalore, India from late July 2025.
